F.-Ulrich Hartl received the Prize for “Biochemical Analytic” of the DGKL
This year, the German Society for Clinical Chemistry and Laboratory Medicine (Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin, DGKL) has awarded F.-Ulrich Hartl, Director at the Max Planck Institute of Biochemistry in Martinsried near Munich, with their “Prize of Biochemical Analytic” which is endowed with the highest amount of prize money awarded by this society. The scientist´s research field, the folding of proteins, also plays an important role in Parkinson´s or Alzheimer´s disease. The award comes with a prize money of 50,000 Euros and was given to the laureate during the 10th annual meeting of the association in Dresden on October 23, 2013.
Since 40 years, the Prize for “Biochemical Analytic“ has paid tribute to scientists who gained important scientific insights by using analytical methods or who enhance analytical methods. F-Ulrich Hartl and Arthur L. Horwich were the first scientists to identify and characterize a certain group of proteins, the so-called chaperones. These important molecular machines help other proteins to fold properly into their three-dimensional structure. The results of the scientists are also relevant for the medical field, because misfolded proteins also play an important role in the development of neurodegenerative diseases. The jury, composed of three members of the DGKL´s executive committee, specially pointed out this connection between basic research and clinical application.
The German Association for Clinical Chemistry and Laboratory Medicine (Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin, DGKL) emerged from the German Society of Clinical Chemistry (Deutschen Gesellschaft für Klinische Chemie, DGKC) and the German Society of Laboratory Medicine (Deutschen Gesellschaft für Laboratoriumsmedizin, DGLM) in 2003. 1100 medical doctors and scientists are member of the society.